Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce

This study aims to describe an association between the Pfizer-BioNTech (BNT162b2) vaccine and decreased risk of symptomatic and asymptomatic infections with SARS-CoV-2 in hospital employees.

Spremljeno u:
Bibliografski detalji
Izdano u:JAMA
Glavni autori: Tang, Li, Hijano, Diego R., Gaur, Aditya H., Geiger, Terrence L., Neufeld, Ellis J., Hoffman, James M., Hayden, Randall T.
Format: Artigo
Jezik:Inglês
Izdano: American Medical Association 2021
Teme:
Research Letter
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8220512/
https://ncbi.nlm.nih.gov/pubmed/33956050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2021.6564
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items